Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
Gamma-ray emitting 111In, which is extensively used for imaging, is also a source of short-range Auger electrons (AE). While exhibiting negligible effect outside cells, these AE become highly toxic near DNA within the cell nucleus. Therefore, these radionuclides can be used as a therapeutic anticanc...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01331/full |
id |
doaj-1245657b71f44cc682e9f85173769347 |
---|---|
record_format |
Article |
spelling |
doaj-1245657b71f44cc682e9f851737693472020-11-24T23:28:38ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-11-01910.3389/fphar.2018.01331411492Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR OverexpressionAndrey A. Rosenkranz0Andrey A. Rosenkranz1Tatiana A. Slastnikova2Tatiana A. Karmakova3Maria S. Vorontsova4Natalia B. Morozova5Vasiliy M. Petriev6Vasiliy M. Petriev7Alexey S. Abrosimov8Yuri V. Khramtsov9Tatiana N. Lupanova10Alexey V. Ulasov11Raisa I. Yakubovskaya12Georgii P. Georgiev13Alexander S. Sobolev14Alexander S. Sobolev15Institute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaFaculty of Biology, Lomonosov Moscow State University, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaNational Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaNational Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, RussiaFaculty of Biology, Lomonosov Moscow State University, Moscow, RussiaGamma-ray emitting 111In, which is extensively used for imaging, is also a source of short-range Auger electrons (AE). While exhibiting negligible effect outside cells, these AE become highly toxic near DNA within the cell nucleus. Therefore, these radionuclides can be used as a therapeutic anticancer agent if delivered precisely into the nuclei of tumor target cells. Modular nanotransporters (MNTs) designed to provide receptor-targeted delivery of short-range therapeutic cargoes into the nuclei of target cells are perspective candidates for specific intracellular delivery of AE emitters. The objective of this study was to evaluate the in vitro and in vivo efficacy of 111In attached MNTs to kill human bladder cancer cells overexpressing epidermal growth factor receptor (EGFR). The cytotoxicity of 111In delivered by the EGFR-targeted MNT (111In-MNT) was greatly enhanced on EJ-, HT-1376-, and 5637-expressing EGFR bladder cancer cell lines compared with 111In non-targeted control. In vivo microSPECT/CT imaging and antitumor efficacy studies revealed prolonged intratumoral retention of 111In-MNT with t½ = 4.1 ± 0.5 days as well as significant dose-dependent tumor growth delay (up to 90% growth inhibition) after local infusion of 111In-MNT in EJ xenograft-bearing mice.https://www.frontiersin.org/article/10.3389/fphar.2018.01331/fullmodular nanotransportersdrug deliveryintracellular transportbladder cancerradionuclide therapyAuger electron emitter |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andrey A. Rosenkranz Andrey A. Rosenkranz Tatiana A. Slastnikova Tatiana A. Karmakova Maria S. Vorontsova Natalia B. Morozova Vasiliy M. Petriev Vasiliy M. Petriev Alexey S. Abrosimov Yuri V. Khramtsov Tatiana N. Lupanova Alexey V. Ulasov Raisa I. Yakubovskaya Georgii P. Georgiev Alexander S. Sobolev Alexander S. Sobolev |
spellingShingle |
Andrey A. Rosenkranz Andrey A. Rosenkranz Tatiana A. Slastnikova Tatiana A. Karmakova Maria S. Vorontsova Natalia B. Morozova Vasiliy M. Petriev Vasiliy M. Petriev Alexey S. Abrosimov Yuri V. Khramtsov Tatiana N. Lupanova Alexey V. Ulasov Raisa I. Yakubovskaya Georgii P. Georgiev Alexander S. Sobolev Alexander S. Sobolev Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression Frontiers in Pharmacology modular nanotransporters drug delivery intracellular transport bladder cancer radionuclide therapy Auger electron emitter |
author_facet |
Andrey A. Rosenkranz Andrey A. Rosenkranz Tatiana A. Slastnikova Tatiana A. Karmakova Maria S. Vorontsova Natalia B. Morozova Vasiliy M. Petriev Vasiliy M. Petriev Alexey S. Abrosimov Yuri V. Khramtsov Tatiana N. Lupanova Alexey V. Ulasov Raisa I. Yakubovskaya Georgii P. Georgiev Alexander S. Sobolev Alexander S. Sobolev |
author_sort |
Andrey A. Rosenkranz |
title |
Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression |
title_short |
Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression |
title_full |
Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression |
title_fullStr |
Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression |
title_full_unstemmed |
Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression |
title_sort |
antitumor activity of auger electron emitter 111in delivered by modular nanotransporter for treatment of bladder cancer with egfr overexpression |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2018-11-01 |
description |
Gamma-ray emitting 111In, which is extensively used for imaging, is also a source of short-range Auger electrons (AE). While exhibiting negligible effect outside cells, these AE become highly toxic near DNA within the cell nucleus. Therefore, these radionuclides can be used as a therapeutic anticancer agent if delivered precisely into the nuclei of tumor target cells. Modular nanotransporters (MNTs) designed to provide receptor-targeted delivery of short-range therapeutic cargoes into the nuclei of target cells are perspective candidates for specific intracellular delivery of AE emitters. The objective of this study was to evaluate the in vitro and in vivo efficacy of 111In attached MNTs to kill human bladder cancer cells overexpressing epidermal growth factor receptor (EGFR). The cytotoxicity of 111In delivered by the EGFR-targeted MNT (111In-MNT) was greatly enhanced on EJ-, HT-1376-, and 5637-expressing EGFR bladder cancer cell lines compared with 111In non-targeted control. In vivo microSPECT/CT imaging and antitumor efficacy studies revealed prolonged intratumoral retention of 111In-MNT with t½ = 4.1 ± 0.5 days as well as significant dose-dependent tumor growth delay (up to 90% growth inhibition) after local infusion of 111In-MNT in EJ xenograft-bearing mice. |
topic |
modular nanotransporters drug delivery intracellular transport bladder cancer radionuclide therapy Auger electron emitter |
url |
https://www.frontiersin.org/article/10.3389/fphar.2018.01331/full |
work_keys_str_mv |
AT andreyarosenkranz antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT andreyarosenkranz antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT tatianaaslastnikova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT tatianaakarmakova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT mariasvorontsova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT nataliabmorozova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT vasiliympetriev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT vasiliympetriev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT alexeysabrosimov antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT yurivkhramtsov antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT tatiananlupanova antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT alexeyvulasov antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT raisaiyakubovskaya antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT georgiipgeorgiev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT alexanderssobolev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression AT alexanderssobolev antitumoractivityofaugerelectronemitter111indeliveredbymodularnanotransporterfortreatmentofbladdercancerwithegfroverexpression |
_version_ |
1725548669290151936 |